Logo image of CRNC

CERENCE INC (CRNC) Stock Fundamental Analysis

NASDAQ:CRNC - Nasdaq - US1567271093 - Common Stock

13.66  +1.08 (+8.59%)

After market: 13.8999 +0.24 (+1.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRNC. CRNC was compared to 285 industry peers in the Software industry. There are concerns on the financial health of CRNC while its profitability can be described as average. CRNC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CRNC was profitable.
CRNC had a positive operating cash flow in the past year.
In the past 5 years CRNC reported 4 times negative net income.
CRNC had a positive operating cash flow in 4 of the past 5 years.
CRNC Yearly Net Income VS EBIT VS OCF VS FCFCRNC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -83.73%, CRNC is doing worse than 89.25% of the companies in the same industry.
Looking at the Return On Equity, with a value of -416.79%, CRNC is doing worse than 86.38% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.54%, CRNC belongs to the best of the industry, outperforming 81.36% of the companies in the same industry.
Industry RankSector Rank
ROA -83.73%
ROE -416.79%
ROIC 7.54%
ROA(3y)-37.21%
ROA(5y)-22.01%
ROE(3y)-156.16%
ROE(5y)-93.19%
ROIC(3y)N/A
ROIC(5y)N/A
CRNC Yearly ROA, ROE, ROICCRNC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

CRNC has a Operating Margin of 13.97%. This is amongst the best in the industry. CRNC outperforms 82.44% of its industry peers.
In the last couple of years the Operating Margin of CRNC has grown nicely.
The Gross Margin of CRNC (73.69%) is better than 62.01% of its industry peers.
In the last couple of years the Gross Margin of CRNC has grown nicely.
Industry RankSector Rank
OM 13.97%
PM (TTM) N/A
GM 73.69%
OM growth 3Y-6.27%
OM growth 5Y3.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y1.84%
CRNC Yearly Profit, Operating, Gross MarginsCRNC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRNC is destroying value.
CRNC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRNC has more shares outstanding
CRNC has a worse debt/assets ratio than last year.
CRNC Yearly Shares OutstandingCRNC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRNC Yearly Total Debt VS Total AssetsCRNC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CRNC has an Altman-Z score of -0.49. This is a bad value and indicates that CRNC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRNC (-0.49) is worse than 74.55% of its industry peers.
CRNC has a debt to FCF ratio of 23.14. This is a negative value and a sign of low solvency as CRNC would need 23.14 years to pay back of all of its debts.
CRNC has a Debt to FCF ratio of 23.14. This is comparable to the rest of the industry: CRNC outperforms 45.52% of its industry peers.
CRNC has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
CRNC's Debt to Equity ratio of 1.38 is on the low side compared to the rest of the industry. CRNC is outperformed by 81.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 23.14
Altman-Z -0.49
ROIC/WACC0.77
WACC9.8%
CRNC Yearly LT Debt VS Equity VS FCFCRNC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CRNC should not have too much problems paying its short term obligations.
CRNC has a Current ratio of 1.22. This is in the lower half of the industry: CRNC underperforms 64.87% of its industry peers.
A Quick Ratio of 1.22 indicates that CRNC should not have too much problems paying its short term obligations.
CRNC has a worse Quick ratio (1.22) than 64.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CRNC Yearly Current Assets VS Current LiabilitesCRNC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 210.81% over the past year.
The earnings per share for CRNC have been decreasing by -23.41% on average. This is quite bad
The Revenue has grown by 12.57% in the past year. This is quite good.
The Revenue has been growing slightly by 1.79% on average over the past years.
EPS 1Y (TTM)210.81%
EPS 3Y-23.41%
EPS 5YN/A
EPS Q2Q%-177.78%
Revenue 1Y (TTM)12.57%
Revenue growth 3Y-5.05%
Revenue growth 5Y1.79%
Sales Q2Q%-32.17%

3.2 Future

CRNC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.55% yearly.
The Revenue is expected to grow by 2.46% on average over the next years.
EPS Next Y-100.68%
EPS Next 2Y-44.59%
EPS Next 3Y-10.81%
EPS Next 5Y26.55%
Revenue Next Year-24.56%
Revenue Next 2Y-7.53%
Revenue Next 3Y2.46%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRNC Yearly Revenue VS EstimatesCRNC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
CRNC Yearly EPS VS EstimatesCRNC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.88, the valuation of CRNC can be described as reasonable.
Based on the Price/Earnings ratio, CRNC is valued cheaply inside the industry as 92.11% of the companies are valued more expensively.
CRNC is valuated cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
CRNC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 11.88
Fwd PE N/A
CRNC Price Earnings VS Forward Price EarningsCRNC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRNC is valued cheaply inside the industry as 91.04% of the companies are valued more expensively.
CRNC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRNC is cheaper than 67.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 47.96
EV/EBITDA 12.09
CRNC Per share dataCRNC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as CRNC's earnings are expected to decrease with -10.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.59%
EPS Next 3Y-10.81%

0

5. Dividend

5.1 Amount

CRNC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CERENCE INC

NASDAQ:CRNC (1/21/2025, 8:00:00 PM)

After market: 13.8999 +0.24 (+1.76%)

13.66

+1.08 (+8.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-21 2024-11-21/bmo
Earnings (Next)02-10 2025-02-10/amc
Inst Owners90.51%
Inst Owner Change0.03%
Ins Owners2.15%
Ins Owner Change42.08%
Market Cap585.06M
Analysts72.31
Price Target7.14 (-47.73%)
Short Float %17.64%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)194.34%
Min EPS beat(2)81.16%
Max EPS beat(2)307.51%
EPS beat(4)4
Avg EPS beat(4)117.64%
Min EPS beat(4)22.04%
Max EPS beat(4)307.51%
EPS beat(8)7
Avg EPS beat(8)107.29%
EPS beat(12)9
Avg EPS beat(12)75.54%
EPS beat(16)13
Avg EPS beat(16)60.99%
Revenue beat(2)2
Avg Revenue beat(2)6.88%
Min Revenue beat(2)1%
Max Revenue beat(2)12.76%
Revenue beat(4)4
Avg Revenue beat(4)6.05%
Min Revenue beat(4)1%
Max Revenue beat(4)12.76%
Revenue beat(8)7
Avg Revenue beat(8)5.06%
Revenue beat(12)8
Avg Revenue beat(12)2.95%
Revenue beat(16)10
Avg Revenue beat(16)2.53%
PT rev (1m)0%
PT rev (3m)36.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-343.34%
EPS NY rev (1m)0%
EPS NY rev (3m)88.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.41%
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE N/A
P/S 1.76
P/FCF 47.96
P/OCF 34.02
P/B 4.15
P/tB N/A
EV/EBITDA 12.09
EPS(TTM)1.15
EY8.42%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.28
FCFY2.09%
OCF(TTM)0.4
OCFY2.94%
SpS7.74
BVpS3.29
TBVpS-3.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -83.73%
ROE -416.79%
ROCE 9.54%
ROIC 7.54%
ROICexc 10.2%
ROICexgc 60.98%
OM 13.97%
PM (TTM) N/A
GM 73.69%
FCFM 3.68%
ROA(3y)-37.21%
ROA(5y)-22.01%
ROE(3y)-156.16%
ROE(5y)-93.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y38.84%
ROICexcg growth 5Y29.35%
ROICexc growth 3Y39.52%
ROICexc growth 5Y37.04%
OM growth 3Y-6.27%
OM growth 5Y3.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y1.84%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 23.14
Debt/EBITDA 3.42
Cap/Depr 47%
Cap/Sales 1.51%
Interest Coverage 7.68
Cash Conversion 30.2%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z -0.49
F-Score4
WACC9.8%
ROIC/WACC0.77
Cap/Depr(3y)50.56%
Cap/Depr(5y)51.08%
Cap/Sales(3y)2.85%
Cap/Sales(5y)3.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)210.81%
EPS 3Y-23.41%
EPS 5YN/A
EPS Q2Q%-177.78%
EPS Next Y-100.68%
EPS Next 2Y-44.59%
EPS Next 3Y-10.81%
EPS Next 5Y26.55%
Revenue 1Y (TTM)12.57%
Revenue growth 3Y-5.05%
Revenue growth 5Y1.79%
Sales Q2Q%-32.17%
Revenue Next Year-24.56%
Revenue Next 2Y-7.53%
Revenue Next 3Y2.46%
Revenue Next 5YN/A
EBIT growth 1Y402.86%
EBIT growth 3Y-11%
EBIT growth 5Y5.05%
EBIT Next Year-74.94%
EBIT Next 3Y48.38%
EBIT Next 5Y31.94%
FCF growth 1Y408.33%
FCF growth 3Y-41.96%
FCF growth 5Y-31.95%
OCF growth 1Y129.28%
OCF growth 3Y-38.63%
OCF growth 5Y-27.87%